Evidence map›Paper›PMID 32290299›Full record

ReviewMolecules (Basel, Switzerland)2020

Molecular and Cellular Mechanisms of Cytotoxic Activity of Vanadium Compounds against Cancer Cells.

Szymon Kowalski, Dariusz Wyrzykowski, Iwona Inkielewicz-Stępniak

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Repurposing Therapeutic Drugs Complexed to Vanadium in Cancer.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  13. Journal of medicinal chemistry · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Nanomedicines in the treatment of colon cancer: a focus on metallodrugs.Drug delivery and translational research · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Szymon KowalskiDepartment of Medical Chemistry, Medical University of Gdansk, 80-211 Gdansk, Poland.ORCID 0000-0001-6539-9161
Dariusz WyrzykowskiFaculty of Chemistry, University of Gdansk, 80-308 Gdansk, Poland.
Iwona Inkielewicz-StępniakDepartment of Medical Chemistry, Medical University of Gdansk, 80-211 Gdansk, Poland.ORCID 0000-0003-1676-2723
Gdańsk Medical University · PLUniversity of Gdańsk · PL

Funding

from the Medical University of Gdansk, Poland the St-46undefined <span style="color:gray;font-size:10px;">undefined</span> the St-46 from the Medical University of Gdansk, Poland
6 · The paper itself

Abstract

Discovering that metals are essential for the structure and function of biomolecules has given a completely new perspective on the role of metal ions in living organisms. Nowadays, the design and synthesis of new metal-based compounds, as well as metal ion binding components, for the treatment of human diseases is one of the main aims of bioinorganic chemistry. One of the areas in vanadium-based compound research is their potential anticancer activity. In this review, we summarize recent molecular and cellular mechanisms in the cytotoxic activity of many different synthetic vanadium complexes as well as inorganic salts. Such mechanisms shall include DNA binding, oxidative stress, cell cycle regulation and programed cell death. We focus mainly on cellular studies involving many type of cancer cell lines trying to highlight some new significant advances.

Indexed as

AnimalsAntineoplastic AgentsCell Cycle CheckpointsDNA DamageHumansMitochondriaOxidative StressReactive Oxygen SpeciesStructure-Activity RelationshipVanadium CompoundsAntineoplastic AgentsReactive Oxygen SpeciesVanadium Compoundscancer cellscellular mechanismscytotoxicitymolecular mechanismsvanadium compounds

Identifiers

PMID32290299
PMCPMC7180481
OpenAlexW3015768334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.